Volume 122, Issue 2 , Pages 280-285, August 2008
Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle age
Background
The association between eczema and asthma is well documented, but the temporal sequence of this association has not been closely examined.
Objectives
To examine the association between childhood eczema and asthma incidence from preadolescence to middle age, and between childhood eczema and asthma persisting to middle age. A further aim was to examine any effect modification by nonallergic childhood exposures on the association between childhood eczema and both childhood asthma and later life incident asthma.
Methods
Data were gathered from the 1968, 1974, and 2004 surveys of the Tasmanian Longitudinal Health Study. Multivariable logistic regression examined the association between childhood eczema and childhood asthma. Cox regression examined the association between childhood eczema and asthma incidence in preadolescence, adolescence, and adult life. Binomial regression examined the association between childhood eczema and childhood asthma persisting to age 44 years.
Results
Childhood eczema was significantly associated with childhood asthma and with incident asthma in preadolescence (hazard ratio [HR], 1.70; 95% CI, 1.05-2.75), adolescence (HR, 2.14; 95% CI, 1.33-3.46), and adult life (HR, 1.63; 95% CI, 1.28-2.09). Although childhood eczema was significantly associated with asthma persisting from childhood to middle age (relative risk, 1.54; 95% CI, 1.17-2.04), this association was no longer evident when adjusted for allergic rhinitis.
Conclusion
Childhood eczema increased the likelihood of childhood asthma, of new-onset asthma in later life and of asthma persisting into middle age.
Key words: Childhood eczema, incident asthma, persisting asthma
Abbreviations used: AD, Atopic dermatitis, OR, Odds ratio, TAHS, Tasmanian Longitudinal Health Study
The Tasmanian Longitudinal Health Study is supported by grants from the National Health and Medical Research Council of Australia, the Victorian and Tasmanian Asthma Foundations, the Clifford Craig Medical Research Trust, and the Royal Hobart Hospital Research Foundation. J.A.B. is supported by a Research Scholarship from the University of Melbourne. G.B.B., M.C.M., J.L.H., and S.C.D. are supported by the National Health and Medical Research Council of Australia.
Disclosure of potential conflict of interest: S. C. Dharmage has received research support from the National Health Medical Research Council, the Asthma Foundation, and the Ilhan Allergy Foundation. M. J. Abramson has served as a member of the Australian Lung Foundation. E. H. Walters has received research support from the National Health Medical Research Council, GlaxoSmithKline, and the Royal Hobart Research Foundation. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)00954-8
doi:10.1016/j.jaci.2008.05.018
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 122, Issue 2 , Pages 280-285, August 2008

